Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Pediatric Nephrology
Published in: Pediatric Nephrology 2/2004

01-02-2004 | Brief Report

Non-glucocorticoid-remediable aldosteronism in an infant with low-renin hypertension

Author: Maricarmen Malagon-Rogers

Published in: Pediatric Nephrology | Issue 2/2004

Login to get access

Abstract

A 6-week-old male with severe hypertension is presented. He was found to have hyperaldosteronism and a negative long polymerase chain reaction (PCR) test for glucocorticoid-remediable aldosteronism. His mother and maternal grandfather also had severe hypertension. A case is made for the possible diagnosis of familial hyperaldosteronism type II at a very early age.
Literature
1.
2.
White P (1996) Inherited forms of mineralocorticoid hypertension. Hypertension 28:927–936PubMed
3.
4.
Gordon RD, Stowasser M (1998) Familial forms broaden the horizons for primary aldosteronism. Trends Endocrinol Metab 9:220–227CrossRef
5.
Jonsson JR, Klemm SA, Tunny TJ, Stowasser M, Gordon RD (1995) A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem Biophys Res Commun 207:565–571CrossRefPubMed
6.
Dluhy RG, Anderson B, Harlin B, Ingelfinger J, Lifton R (2001) Glucocorticoid-remediable aldosteronism is associated with severe hypertension in early childhood. J Pediatr 138:715–720CrossRefPubMed
7.
Stowasser M, Gunasekera TG, Gordon RD (2001) Familial varieties of primary aldosteronism. Clin Exp Pharmacol Physiol 28:1087–1090CrossRefPubMed
8.
Stowasser M, Gordon RD, Tunny TJ, Klemm SA, Finn WL, Krek AL (1992) Familial hyperaldosteronism type II: five families with a new variety of primary aldosteronism. Clin Exp Pharmacol Physiol 19:319–322PubMed
9.
Laferty AR, Torpy DJ, Stowasser M, Taymans SE, Lin JP, Huggard P, Gordon RD, Stratakis CA (2000) A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet 37:831–835CrossRefPubMed
10.
Litchfield WR, New MI, Coolidge C, Lifton RP, Dluhy RG (1997) Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 82:3570–3573PubMed
Metadata
Title
Non-glucocorticoid-remediable aldosteronism in an infant with low-renin hypertension
Author
Maricarmen Malagon-Rogers
Publication date
01-02-2004
Publisher
Springer-Verlag
Published in
Pediatric Nephrology / Issue 2/2004
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-003-1339-2

Other articles of this Issue 2/2004

Pediatric Nephrology 2/2004 Go to the issue

Original Article

Impaired vascular endothelium-dependent relaxation in Henoch-Schönlein purpura

Review

Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome

Original Article

Renal replacement therapy for acute renal failure in children: European Guidelines

Original Article

Citrate anticoagulation in pediatric continuous venovenous hemofiltration

Brief Report

Nephrolithiasis in a child with glucose-galactose malabsorption

Editorial Commentary

Re-establishment of the ERA-EDTA Registry